v3.26.1
Note 7 - Segment Reporting (Tables)
3 Months Ended
Mar. 31, 2026
Notes Tables  
Segment Reporting, Reconciliation of Profit (Loss) by Segment to Consolidated [Table Text Block]
  

Three Months Ended

 
  

March 31,

 
  

2026

  

2025

 

Revenues

 $  $ 

Less:

        

Clinical and regulatory

  1,690,402   1,706,705 

Manufacturing

  612,212   483,065 

Research

  408,834   308,327 

General and administrative support

  1,664,101   1,286,422 

Non-cash expenses(1)

  118,635   184,773 

Other income

  31,748   4,771 

Plus:

        

Realized and unrealized gain (loss)

  541   (80)

Segment and net loss

 $4,461,895  $3,964,601